ICARES Medicus, Inc. (TPEX:6612)
122.00
+3.50 (2.95%)
May 23, 2025, 1:30 PM CST
ICARES Medicus Revenue
ICARES Medicus had revenue of 297.65M TWD in the quarter ending March 31, 2025, with 84.87% growth. This brings the company's revenue in the last twelve months to 996.44M, up 61.22% year-over-year. In the year 2024, ICARES Medicus had annual revenue of 859.79M with 42.01% growth.
Revenue (ttm)
996.44M
Revenue Growth
+61.22%
P/S Ratio
5.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
Dec 31, 2020 | 362.67M | -56.70M | -13.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Oneness Biotech | 117.33M |
Center Laboratories | 1.63B |
Pegavision | 6.69B |